Oculis Holding (NasdaqGM:OCS) Earnings Call Presentation

Rethinking Ophthalmology Privosegtor FDA update Corporate Update 3 Oculis (Nasdaq / XICE: OCS) Three registrational programs in Neuro-Ophthalmic and Retina indications provide multi- billion-dollar market opportunities October 6th, 2025 Safe Harbor Statements Cautionary note on forward-looking statements These slides and the accompanying oral presentation contain forward-looking statements and information. The use of words such as "may," "might," "will," "should," "expect," "plan," "anticipate," "believe," ...